Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity
- PMID: 19951182
- PMCID: PMC2831647
- DOI: 10.1089/vim.2009.0068
Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity
Abstract
Despite a safe and effective vaccine, endemic rubella remains a problem in developing countries. Isolated cases and outbreaks can occur in areas with high vaccine coverage. Individuals, especially pregnant women who remain unimmunized or do not seroconvert, are susceptible to infection and their infants are at risk for congenital rubella syndrome (CRS). Both humoral and cellular immune responses contribute to immune protection. Classically, immunity to rubella has been assessed through the detection of rubella-specific antibody titers. In this study we examined correlates of both humoral and cellular immunity in a large population of immunized young adults in Olmsted County, MN. We were unable to find any significant correlation between cytokine production after in-vitro rubella stimulation and serum antibody titers.
Figures
Similar articles
-
Characterization of humoral and cellular immunity to rubella vaccine in four distinct cohorts.Immunol Res. 2014 Jan;58(1):1-8. doi: 10.1007/s12026-013-8475-y. Immunol Res. 2014. PMID: 24375276 Free PMC article.
-
Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination.Clin Exp Immunol. 2005 Dec;142(3):498-504. doi: 10.1111/j.1365-2249.2005.02931.x. Clin Exp Immunol. 2005. PMID: 16297162 Free PMC article.
-
Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.Vaccine. 2020 Jan 29;38(5):1249-1257. doi: 10.1016/j.vaccine.2019.11.004. Epub 2019 Nov 12. Vaccine. 2020. PMID: 31732325 Free PMC article.
-
Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers.Vaccine. 2015 Nov 9;33(45):6093-8. doi: 10.1016/j.vaccine.2015.06.113. Epub 2015 Aug 12. Vaccine. 2015. PMID: 26275479
-
Successes and challenges for preventing measles, mumps and rubella by vaccination.Curr Opin Virol. 2019 Feb;34:110-116. doi: 10.1016/j.coviro.2019.01.002. Epub 2019 Mar 7. Curr Opin Virol. 2019. PMID: 30852425 Review.
Cited by
-
Serosurveillance for Measles and Rubella.Vaccines (Basel). 2024 Jul 22;12(7):816. doi: 10.3390/vaccines12070816. Vaccines (Basel). 2024. PMID: 39066453 Free PMC article. Review.
-
Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine.Vaccine. 2020 Nov 25;38(50):7897-7904. doi: 10.1016/j.vaccine.2020.10.071. Epub 2020 Nov 4. Vaccine. 2020. PMID: 33158591 Free PMC article.
-
T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.Int Rev Cell Mol Biol. 2019;342:175-263. doi: 10.1016/bs.ircmb.2018.07.006. Epub 2018 Oct 24. Int Rev Cell Mol Biol. 2019. PMID: 30635091 Free PMC article. Review.
-
Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology.PLoS One. 2017 Nov 16;12(11):e0188149. doi: 10.1371/journal.pone.0188149. eCollection 2017. PLoS One. 2017. PMID: 29145521 Free PMC article.
-
High-throughput assay optimization and statistical interpolation of rubella-specific neutralizing antibody titers.Clin Vaccine Immunol. 2014 Mar;21(3):340-6. doi: 10.1128/CVI.00681-13. Epub 2014 Jan 3. Clin Vaccine Immunol. 2014. PMID: 24391140 Free PMC article.
References
-
- Akaboshi I. Nagayoshi I. Omura M. Iwaki K. Elevated serum levels of interleukin-10 in children with acute rubella infection. Scand J Infect Dis. 2001;33:462–465. - PubMed
-
- Bautista-Lopez N. Ward BJ. Mills E. McCormick D. Martel N. Ratnam S. Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination. Vaccine. 2000;18:1393–1401. - PubMed
-
- Boulianne N. De Serres G. Ratnam S. Ward BJ. Joly JR. Duval B. Measles, mumps, and rubella antibodies in children 5–6 years after immunization: effect of vaccine type and age at vaccination. Vaccine. 1995;13:1611–1616. - PubMed
-
- Chabalgoity JA. Baz A. Rial A. Grille S. The relevance of cytokines for development of protective immunity and rational design of vaccines. Cytokine Growth Factor Rev. 2007;18:195–207. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources